Search Results - "Soulban, Graziella"

Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain by As-Sanie, Sawsan, Abrao, Mauricio S., Reznichenko, Galyna, Wilk, Krzysztof, Zhong, Yi, Perry, Julie, Hunsche, Elke, Soulban, Graziella, Becker, Christian M.

“…To evaluate the effect of relugolix combination therapy (relugolix CT; 40 mg relugolix, 1 mg estradiol, and 0.5 mg norethisterone acetate) for up to 2 years in…”
Get full text

SUSTAINED IMPROVEMENT IN PHYSICAL FUNCTION AND QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN TREATED WITH RELUGOLIX COMBINATION THERAPY OVER 104 WEEKS: SPIRIT LONG-TERM EXTENSION STUDY by As-Sanie, Sawsan, Mehedintu, Claudia, Mathur, Vandana, Soulban, Graziella, Hunsche, Elke, Imm, So Jung, Giudice, Linda C.

Get full text

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids by Al-Hendy, Ayman, Venturella, Roberta, Arjona Ferreira, Juan Camilo, Li, Yulan, Soulban, Graziella, Wagman, Rachel B., Lukes, Andrea S.

“…In the pivotal LIBERTY 1 and 2 trials and long-term extension study, once-daily relugolix combination therapy (40 mg relugolix, 1 mg estradiol, 0.5 mg…”
Get full text

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial by Archer, David F, Goldstein, Steven R, Simon, James A, Waldbaum, Arthur S, Sussman, Steven A, Altomare, Corrado, Zhu, Julie, Yoshida, Yuki, Schaffer, Sam, Soulban, Graziella

“…OBJECTIVE:To evaluate the safety and efficacy of ospemifene for the treatment of moderate to severe vaginal dryness in postmenopausal women with vulvovaginal…”
Get full text

PD20-06 EVALUATION OF VULVAR HEALTH FROM PHOTOGRAPHS by Goldstein, Irwin, Simon, James, Kaunitz, Andrew, Altomare, Corrado, Yoshida, Yuki, Zhu, Julie, Schaffer, Samuel, Soulban, Graziella

Get full text

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices by Goldstein, Irwin, Simon, James A, Kaunitz, Andrew M, Altomare, Corrado, Yoshida, Yuki, Zhu, Julie, Schaffer, Sam, Soulban, Graziella

“…OBJECTIVE:To prospectively evaluate the effects of ospemifene on the vulva and vagina in postmenopausal women using vulvar-vestibular photography and direct…”
Get full text

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices by Goldstein, Irwin, Simon, James A, Kaunitz, Andrew M, Altomare, Corrado, Yoshida, Yuki, Zhu, Julie, Schaffer, Sam, Soulban, Graziella

“…To prospectively evaluate the effects of ospemifene on the vulva and vagina in postmenopausal women using vulvar-vestibular photography and direct visual…”
Get full text

Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in Human Immunodeficiency Virus-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Multicenter, Double-Blind Placebo-Controlled Phase 3 Trials with Safety Extension Data by Falutz, Julian, Mamputu, Jean-Claude, Potvin, Diane, Moyle, Graeme, Soulban, Graziella, Loughrey, Helen, Marsolais, Christian, Turner, Ralph, Grinspoon, Steven

“…Context: HIV patients treated with antiretroviral therapy (ART) often develop increased visceral adipose tissue (VAT). Objective: Our objective was to perform…”
Get full text

Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia by Faught, Brooke M, Soulban, Graziella, Yeaw, Jason, Maroun, Christiane, Coyle, Katharine, Schaffer, Samuel, DeKoven, Mitch

“…Objective was to compare adherence and persistence, as well as direct healthcare costs and utilization, of ospemifene to available local estrogen therapies…”
Get full text

Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin by Stanley, Takara L., Falutz, Julian, Marsolais, Christian, Morin, Josée, Soulban, Graziella, Mamputu, Jean-Claude, Assaad, Hani, Turner, Ralph, Grinspoon, Steven K.

“…Background. Tesamorelin, a growth hormone—releasing hormone analogue, decreases visceral adipose tissue (VAT) by 15%—20% over 6—12 months in individuals with…”
Get full text

Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction by STANLEY, Takara L, FALUTZ, Julian, MAMPUTU, Jean-Claude, SOULBAN, Graziella, POTVIN, Diane, GRINSPOON, Steven K

“…To report the effects of tesamorelin, a growth hormone-releasing hormone analogue, on inflammatory and fibrinolytic markers and to relate these effects to…”
Get full text

O2-05-08: A phase III study of the efficacy, safety and disease modification effect of tramiprosate in mild-to-moderate Alzheimer’s disease by Aisen, Paul, Gauthier, Serge, Briand, Richard, Saumier, Daniel, Soulban, Graziella, Garceau, Denis

Get full text

O2-05-08 by Aisen, Paul, Gauthier, Serge, Briand, Richard, Saumier, Daniel, Soulban, Graziella, Garceau, Denis

Get full text

Temporal variation in the effects of warfarin on the vitamin K cycle by Soulban, G, Labrecque, G, Bélanger, P M

“…In this in vivo study, the time-dependent effect of oral sodium warfarin was studied in male rats synchronized under a 12-hr light-dark cycle (light…”
Get more information